In the BioHarmony Drug Report Database
Levorphanol
Levo-dromoran (levorphanol) is a small molecule pharmaceutical. Levorphanol was first approved as Levo-dromoran on 1991-12-19. It is used to treat pain in the USA. The pharmaceutical is active against mu-type opioid receptor. In addition, it is known to target glutamate receptor ionotropic, NMDA 2C.
Trade Name
|
Levo-dromoran |
|---|---|
Common Name
|
levorphanol |
ChEMBL ID
|
CHEMBL592 |
Indication
|
pain |
Drug Class
|
Narcotic antagonists/agonists (morphinan derivatives) |
Image (chem structure or protein)